 |
市場調查報告書
商品編碼
2051196
Lantus市場：依年齡層、濃度、劑型、最終用戶、通路及地區分類Lantus Market, By Age Group, By Strength, By Dosage Form, By End User, By Distribution Channel, By Geography |
||||||
據估計，2026年來得時市值為22.4億美元，預計到2033年將達到33.7億美元。預計從2026年到2033年，其複合年成長率將達到6.0%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 22.4億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 6.00% | 2033年市場規模預測： | 33.7億美元 |
全球來得時（Lantus）市場佔據糖尿病治療市場的重要佔有率，專注於為第1型和第2型糖尿病患者提供持續血糖控制的長效胰島素製劑。來得時（甘精胰島素）是一種合成的長效基礎胰島素類似物，能夠模擬人體自然的胰島素分泌模式，每日一次給藥即可達到24小時血糖控制。該市場涵蓋多種劑型，例如管瓶和預填充注射筆，以滿足全球不同患者的偏好和醫療保健系統的需求。該市場的重要性源自於全球糖尿病盛行率的不斷上升，目前全球已有超過5.37億成年人患有糖尿病，預計未來幾十年這一數字將顯著成長。胰島素輸注系統的技術進步，以及病患依從性和治療效果的提高，已使來得時成為糖尿病管理方案中的基石療法。市場動態受到專利到期、生物相似藥的競爭、法律規範、醫療保健基礎設施的發展以及強調個性化糖尿病護理方法以實現最佳治療效果的治療指南演變等因素的影響。
市場動態
全球來得時（Lantus）市場受多種關鍵因素驅動，這些因素持續塑造其成長軌跡。其中最主要的因素是全球糖尿病（尤其是第2型糖尿病）盛行率的不斷上升，而這又受到久坐不動的生活方式、飲食習慣改變以及已開發經濟體和新興經濟體肥胖率上升的影響。與傳統胰島素製劑相比，來得時具有更優的藥物動力學特性，其胰島素峰值作用更低，低血糖事件發生率也更低，這有助於醫生選擇和患者接受。同時，給藥機制的不斷創新，例如智慧胰島素筆和連網型設備，正在提高治療依從性和監測能力。然而，該市場也面臨著許多限制因素，包括專利到期，為生物相似藥的競爭打開了大門，並對定價策略和市場佔有率趨勢產生了重大影響。此外，新製劑和給藥系統嚴格的監管核准流程也阻礙了市場准入和擴張。另外，複雜的健保報銷環境和保險覆蓋範圍的多樣化，以及控制醫療成本的壓力（尤其是在已開發市場），都限制了市場的可及性和成長潛力。儘管面臨諸多挑戰，亞太、拉丁美洲和非洲等新興市場醫療基礎設施的擴張也帶來了巨大的機會。雖然這些地區的糖尿病盛行率正在迅速上升，但治療覆蓋率仍然很低，這表明市場潛力尚未充分開發。數位健康技術的整合，例如持續血糖監測系統和人工智慧驅動的糖尿病管理平台，為改善患者療效和實現市場差異化提供了機會。同時，人們對糖尿病併發症和血糖控制重要性的認知不斷提高，推動了已開發國家和開發中國家醫療體系對高品質胰島素療法（如來得時）的需求。
本次調查的主要特點
- 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究根據以下參數創建了全球 Lantus 市場主要公司的概況：公司亮點、產品系列、主要特徵、財務表現和策略。
- 本次調查涵蓋的主要公司包括賽諾菲。
- 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 這份全球來得時市場報告旨在為行業內的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以利用各種用於分析全球來得時市場的策略矩陣，更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監管與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特的分析
- 市場機遇
- 監管趨勢
- 主要進展
- 產業趨勢
- 流行病學
- 治療方法方案分析
- 價格差異化分析（來得時及其生物相似藥）
- 救贖方案
- 美國藥物依從性與轉換率分析
- 疾病意識計劃
第4章：全球來得時市場：依年齡層別分類，2021-2033年
- 兒童
- 成人
第5章 全球來得時市場：依強度分類，2021-2033年
- 10 mL
- 3 mL
第6章 全球來得時市場：依劑型分類，2021-2033年
- 多管瓶小瓶
- 一次預填充筆
第7章：全球來得時市場：依最終用戶分類，2021-2033年
- 醫院
- 專科診所
- 長期照護機構
- 其他（例如，居家照護環境）
第8章：全球來得時市場：依通路分類，2021-2033年
- 醫院藥房
- 零售藥房
- 網路藥房
第9章：全球來得時市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第10章 競爭格局
- Sanofi
第11章 分析師建議
- 機會分析
- 分析師意見
- Coherent Opportunity Map
第12章 參考文獻與調查方法
- 參考
- 調查方法
- 關於本公司
Lantus Market is estimated to be valued at USD 2.24 Bn in 2026 and is expected to reach USD 3.37 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.24 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.00% | 2033 Value Projection: | USD 3.37 Bn |
The global Lantus market represents a critical segment within the diabetes therapeutics landscape, focusing on long-acting insulin formulations designed to provide sustained glycemic control for patients with Type 1 and Type 2 diabetes mellitus. Lantus (insulin glargine) is a synthetic, long-acting basal insulin analog that mimics the body's natural insulin production pattern, offering 24-hour glucose control with once-daily dosing. This market encompasses various formulations including vials, pre-filled pens, catering to diverse patient preferences and healthcare delivery systems globally. The market's significance stems from the growing prevalence of diabetes worldwide, affecting over 537 million adults globally, with projections indicating substantial increases in the coming decades. Technological advancements in insulin delivery systems, coupled with improved patient compliance and outcomes, have positioned Lantus as a cornerstone therapy in diabetes management protocols. The market dynamics are influenced by factors including patent expirations, biosimilar competition, regulatory frameworks, healthcare infrastructure development, and evolving treatment guidelines that emphasize personalized diabetes care approaches for optimal patient outcomes.
Market Dynamics
The global Lantus market is propelled by several key drivers that continue to shape its growth trajectory, with the primary catalyst being the escalating global diabetes epidemic, particularly Type 2 diabetes, driven by sedentary lifestyles, dietary changes, and increasing obesity rates across developed and emerging economies. The superior pharmacokinetic profile of Lantus, offering peak less insulin action and reduced hypoglycemic episodes compared to conventional insulin formulations, drives physician preference and patient adoption, while continuous innovation in delivery mechanisms including smart insulin pens and connected devices enhances treatment adherence and monitoring capabilities. However, the market faces significant restraints including patent cliff challenges that have opened doors for biosimilar competition, substantially impacting pricing strategies and market share dynamics, while stringent regulatory approval processes for new formulations and delivery systems create barriers to market entry and expansion. Additionally, healthcare cost containment pressures, particularly in developed markets, along with complex reimbursement landscapes and varying insurance coverage policies, limit market accessibility and growth potential. Despite these challenges, substantial opportunities emerge from expanding healthcare infrastructure in emerging markets across Asia-Pacific, Latin America, and Africa, where diabetes prevalence is rising rapidly but treatment penetration remains low, creating untapped market potential. The integration of digital health technologies, including continuous glucose monitoring systems and artificial intelligence-driven diabetes management platforms, presents opportunities for enhanced patient outcomes and market differentiation, while growing awareness about diabetes complications and the importance of glycemic control drives demand for premium insulin therapies like Lantus in both developed and developing healthcare systems.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global Lantus market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key company covered as a part of this study include Sanofi.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global Lantus market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Lantus market.
Market Segmentation
- Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Pediatric
- Adult
- Strength Insights (Revenue, USD Bn, 2021 - 2033)
- 10 mL
- 3 mL
- Dosage Form Insights (Revenue, USD Bn, 2021 - 2033)
- Multi-dose Vial
- Single Patient use Prefilled pen
- End User Insights (Revenue, USD, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Long-Term Care Facilities
- Others (Home Care Settings, etc.)
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Sanofi
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Lantus Market, By Age Group
- Global Lantus Market, By Strength
- Global Lantus Market, By Dosage Form
- Global Lantus Market, By End User
- Global Lantus Market, By Distribution Channel
- Global Lantus Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
- Epidemiology
- Treatment Option Analysis
- Price Differentiation Analysis (Lantus and Biosimilars)
- Reimbursement Scenario
- Adherence and Switch Rate Analysis in U.S.
- Disease Awareness Programs
4. Global Lantus Market, By Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Lantus Market, By Strength, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- 10 mL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- 3 mL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Lantus Market, By Dosage Form, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Multi-dose Vial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Single Patient use Prefilled pen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Lantus Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Long-Term Care Facilities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Home Care Settings, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Lantus Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Lantus Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
